No Data
01931 IVD MEDICAL
Watchlist- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About IVD MEDICAL Company
Huajian Medical Holdings Limited was incorporated under Cayman Islands law on January 15, 2016. Its main business is investment holding. The Group has three subsidiaries in Hong Kong, China: Weishida Medical Co., Ltd., China Testing International Co., Ltd., and Avid (China) Co., Ltd. Each of the three subsidiaries has subsidiaries or branches in mainland China and offices in major cities across the country. The company has nearly 550 employees and is mainly engaged in the development, production and sale of medical instruments and consumables for in vitro diagnosis. Its business covers mainland China and Hong Kong. Since the establishment of Weishida Medical Co., Ltd. in 1993, we have focused on in vitro diagnosis business. After more than 20 years of development, we have now become the leading company specializing in in in vitro diagnosis business in China, providing value-added products and services to the Chinese laboratory industry.
Revenue Breakdown
News
Sysmex Unit Plans to Acquire Shares in IVD Medical's Subsidiary
Sysmex's (TYO:6869) unit, Sysmex Shanghai, plans to inject capital to and become a shareholder of IVD Medical Holding's (HKG:1931) subsidiary, Vastec Medical Equipment (Shanghai), as part of a coopera
Huajian Medical and Heeson Meikang signed a strategic cooperation agreement for the coagulation products business of both parties
Huajian Medical (01931) announced that on November 2, 2023, Weishida Medical Equipment (Shanghai) Co., Ltd., a wholly-owned subsidiary of the company, and Heeson Meikang Medical Electronics (Shanghai) Co., Ltd. signed a number of agreements for strategic cooperation in the coagulation product business between the two sides. Considering the history of cooperation over the past 26 years, in order to better cope with future market changes, Wisda and Heeson Meikang Shanghai agreed that the two sides should deepen cooperation and sign a strategic cooperation agreement for this purpose. The main contents include (subject to a number of regular prerequisites) the two parties revising Wisda's existing distribution rights and Weishida's equity structure
IVD Medical Holding Limited (HKG:1931) Adds HK$515m in Market Cap and Insiders Have a 44% Stake in That Gain
Key Insights IVD Medical Holding's significant insider ownership suggests inherent interests in company's expansion 59% of the business is held by the top 3 shareholders Past performance of a com